Stem cell-based therapies for osteoarthritis: challenges and opportunities
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Regenerative medicine offers the exciting potential of developing alternatives to total joint replacement for treating osteoarthritis. In this article, we highlight recent work that addresses key challenges of stem cell-based therapies for osteoarthritis and provide examples of innovative ways in which stem cells can aid in the treatment of osteoarthritis. RECENT FINDINGS: Significant progress has been made in understanding the challenges to successful stem cell therapy, such as the effects of age or disease on stem cell properties, altered stem cell function due to an inflammatory joint environment and phenotypic instability in vivo. Novel scaffold designs have been shown to enhance the mechanical properties of tissue-engineered cartilage and have also improved the integration of newly formed tissue within the joint. Emerging strategies such as injecting stem cells directly into the joint, manipulating endogenous stem cells to enhance regenerative capacity and utilizing stem cells for drug discovery have expanded the potential uses of stem cells in treating osteoarthritis. SUMMARY: Several recent studies have greatly advanced the development and preclinical evaluation of potential stem cell-based treatments for osteoarthritis through novel approaches focused on cell therapy, tissue engineering and drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992
Inflammation in osteoarthritis
Goldring, M. B., & Otero, M. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328349c2b1 · Cited by 1,462
Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation
Prockop, D. J., & Youn Oh, J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.211 · Cited by 816 · cited 1×
“altering the balance of inflammation and regeneration in numerous other injury models [27,28].”
Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis
Koh, Y.-G., & Choi, Y.-J. (2012) · The Knee · doi:10.1016/j.knee.2012.04.001 · Cited by 392
Cited by
Xu, X., Liang, Y., Li, X., Ouyang, K., Wang, M., Cao, T., Li, W., Liu, J., Xiong, J., Li, B., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120539 · Cited by 377
Vonk, L. A., van Dooremalen, S. F. J., Liv, N., Klumperman, J., Coffer, P. J., Saris, D. B. F., & Lorenowicz, M. J. (2018) · Theranostics · doi:10.7150/thno.20746 · Cited by 346
Rowland, C. R., Lennon, D. P., Caplan, A. I., & Guilak, F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.027 · Cited by 190
Self-citationDecellularized xenografts in regenerative medicine: From processing to clinical application
Capella‐Monsonís, H., & Zeugolis, D. I. (2021) · Xenotransplantation · doi:10.1111/xen.12683 · Cited by 57
Metadata
- Authors
- Diekman, B. O., & Guilak, F.
- Venue
- Current Opinion in Rheumatology
- Published
- 2013-01
- Volume
- 25
- Issue
- 1
- Pages
- 119-126
- ISSN
- 1040-8711 (ISSN-L)
- OpenAlex
- W2135763340
- Cited by
- 143
- References
- 4
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stem cell-based therapies for osteoarthritis: challenges and opportunities. https://app.cochat.ai/papers/10.1097/bor.0b013e32835aa28d
- The paper
- Diekman, B. O., & Guilak, F. (2013). Stem cell-based therapies for osteoarthritis: challenges and opportunities. Current Opinion in Rheumatology. https://doi.org/10.1097/bor.0b013e32835aa28d
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.